Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P. H. Chandrasekar

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
International Journal of Antimicrobial Agents|August 26, 1999
Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agentE K Manavathu, J A Vazquez, P H Chandrasekar
Chemotherapy|January 1, 1986
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureusJ Unowsky, P H Chandrasekar, W DeLorenzo, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2012
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatusS Krishnan Natesan, Wenjuan Wu, J L Cutright, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Comparative efficacy of ketoconazole and mebendazole in experimental trichinosisJ A Hess, P H Chandrasekar, M Mortiere, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureusP H Chandrasekar, D P Levine, S Price, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)E K Manavathu, J L Cutright, D Loebenberg, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Enterococcal superinfection and colonization with aztreonam therapyP H Chandrasekar, B R Smith, J L LeFrock, et al.
Cancer|July 1, 1991
Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndromeE A Poplin, C J Gordon, T J Piskorowski, et al.
Drug Intelligence & Clinical Pharmacy|November 1, 1987
Increased theophylline concentrations secondary to ciprofloxacinM J Rybak, S K Bowles, P H Chandrasekar, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2001
Inhibition of H(+)-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketoneE K Manavathu, J R Dimmock, S C Vashishtha, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Antimicrobial Agents|August 26, 1999
Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agentE K Manavathu, J A Vazquez, P H Chandrasekar
Chemotherapy|January 1, 1986
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureusJ Unowsky, P H Chandrasekar, W DeLorenzo, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2012
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatusS Krishnan Natesan, Wenjuan Wu, J L Cutright, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Comparative efficacy of ketoconazole and mebendazole in experimental trichinosisJ A Hess, P H Chandrasekar, M Mortiere, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureusP H Chandrasekar, D P Levine, S Price, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)E K Manavathu, J L Cutright, D Loebenberg, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Enterococcal superinfection and colonization with aztreonam therapyP H Chandrasekar, B R Smith, J L LeFrock, et al.
Cancer|July 1, 1991
Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndromeE A Poplin, C J Gordon, T J Piskorowski, et al.
Drug Intelligence & Clinical Pharmacy|November 1, 1987
Increased theophylline concentrations secondary to ciprofloxacinM J Rybak, S K Bowles, P H Chandrasekar, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2001
Inhibition of H(+)-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketoneE K Manavathu, J R Dimmock, S C Vashishtha, et al.
Pageof 8